ID: ALA3957163

Max Phase: Preclinical

Molecular Formula: C26H29N3OS

Molecular Weight: 431.61

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=c1ccc2ccccc2n1CCCCCN1CCN(c2cccc3sccc23)CC1

Standard InChI:  InChI=1S/C26H29N3OS/c30-26-12-11-21-7-2-3-8-23(21)29(26)15-5-1-4-14-27-16-18-28(19-17-27)24-9-6-10-25-22(24)13-20-31-25/h2-3,6-13,20H,1,4-5,14-19H2

Standard InChI Key:  QRSVODFJOPEHOT-UHFFFAOYSA-N

Associated Targets(non-human)

Serotonin 2a (5-HT2a) receptor 3540 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 431.61Molecular Weight (Monoisotopic): 431.2031AlogP: 5.21#Rotatable Bonds: 7
Polar Surface Area: 28.48Molecular Species: BASEHBA: 5HBD: 0
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 8.55CX LogP: 5.12CX LogD: 3.93
Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.38Np Likeness Score: -1.53

References

1.  (2015)  Piperazine-substituted benzothiophenes for treatment of mental disorders, 

Source

Source(1):